Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management. (2022)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2022.104038
PubMed Identifier: 35500537
Publication URI: http://europepmc.org/abstract/MED/35500537
Type: Journal Article/Review
Volume: 80
Parent Publication: EBioMedicine
ISSN: 2352-3964